Stock & Company Details
Castle Biosciences Inc $CSTL
Price:
N/A
N/A
31M
$1B
52 Week High:
N/A
10 Day Average Volume:
N/A
-51.51
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CSTL technical indicators
Latest Castle Biosciences Inc (CSTL) indicator readings as of 2026-08-28.
CSTL's 14-day RSI is 62.6, in neutral territory. At $33.50 it is trading 13.8% above its 200-day moving average of $29.45, and above its 50-day average of $27.18. Price sits in the middle of its Bollinger Bands ($28.56 to $35.38). ADX reads 43.7, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Finance Bot
Ask your questions
Start by typing a question below.
